Medical Editor: John P. Cunha, DO, FACOEP
What Is Xtoro?
Xtoro (finafloxacin otic suspension) is an antibiotic used to treat acute otitis externa (AOE), also known as swimmer's ear, with or without an otowick, caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus in patients age 1 year and older.
What Are Side Effects of Xtoro?
Common side effects of Xtoro include:
- ear itching, and
Seek medical care or call 911 at once if you have the following serious side effects:
- Serious eye symptoms such as sudden vision loss, blurred vision, tunnel vision, eye pain or swelling, or seeing halos around lights;
- Serious heart symptoms such as fast, irregular, or pounding heartbeats; fluttering in your chest; shortness of breath; and sudden dizziness, lightheartedness, or passing out;
- Severe headache, confusion, slurred speech, arm or leg weakness, trouble walking, loss of coordination, feeling unsteady, very stiff muscles, high fever, profuse sweating, or tremors.
This document does not contain all possible side effects and others may occur. Check with your physician for additional information about side effects.
Dosage for Xtoro
The dose of Xtoro is four drops instilled into the affected ear(s) twice daily for seven days.
What Drugs, Substances, or Supplements Interact with Xtoro?
Xtoro may interact with other drugs. Tell your doctor all medications and supplements you use.
Xtoro During Pregnancy or Breastfeeding
During pregnancy, Xtoro should be used only if prescribed. This drug passes into breast milk in small amounts. Consult your doctor before breastfeeding.
Our Xtoro (finafloxacin otic suspension) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Clinical Studies Experience
Because clinical studies are conducted under widely varying conditions, adverse reaction rates observed in the clinical studies of a drug cannot be directly compared to rates in the clinical studies of another drug and may not reflect the rates observed in practice.
A total of 618 patients were treated with XTORO in two Phase 3 clinical trials. The most frequently reported adverse reactions of those exposed to XTORO occurring at an incidence of 1% included ear pruritus and nausea.
Read the entire FDA prescribing information for Xtoro (Finafloxacin Otic Suspension)
© Xtoro Patient Information is supplied by Cerner Multum, Inc. and Xtoro Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.
Health Solutions From Our Sponsors